Skip to main content
KAMADA LTD logo

KAMADA LTD — Investor Relations & Filings

Ticker · KMDA US Manufacturing
Filings indexed 445 across all filing types
Latest filing 2020-02-13 Major Shareholding Noti…
Country US United States of America
Listing US KMDA

About KAMADA LTD

https://www.kamada.com/

Kamada Ltd. is a vertically integrated global biopharmaceutical company focused on specialty plasma-derived therapeutics. The company engages in the research, development, manufacturing, and commercialization of protein therapeutics derived from human plasma. It utilizes a proprietary platform technology for protein extraction and purification to address rare and serious conditions. Key therapeutic areas include Alpha-1 Antitrypsin Deficiency (AATD), with a development pipeline featuring an inhaled AAT therapy, and the prevention of Cytomegalovirus (CMV) disease in transplant recipients. The company's operations also encompass the collection of human plasma through its U.S.-based subsidiary.

Recent filings

Filing Released Lang Actions
AMENDMENT NO.5 TO SCHEDULE 13G
Major Shareholding Notification
2020-02-13 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2020-02-13 English
SC 13G/A
Major Shareholding Notification
2020-02-12 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2020-02-12 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2020-02-05 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-01-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.